A Europe-based medical affairs team within a leading global pharmaceutical company wanted to obtain opinions and feedback on key study data presented at a medical congress. The team already planned to conduct a face-to-face meeting with one group of oncologists, but also wanted to solicit feedback from a different group of oncologists who normally would not have been included in the face-to-face meeting.
The team’s objectives included:
- Gather first impressions of survival data in the study
- Understand opinions about data related to a specific class of drugs
- Learn about different patient treatment strategies
- Obtain the oncologists’ personal experience with a particular therapy